Prognostic value of elevated postoperative high-sensitivity troponin T in diabetes mellitus patients for ischemic events within 12 months after PCI in ACS patients: a retrospective cohort study

ObjectiveThis study aimed to investigate the prognostic value of high-sensitivity cardiac troponin T (hs-cTnT) levels and diabetes mellitus (DM) on ischemic events within 12 months after percutaneous coronary intervention (PCI) in acute coronary syndrome(ACS) patients.MethodsThis retrospective cohor...

Full description

Saved in:
Bibliographic Details
Main Authors: Xuefei Mu, Miaohan Qiu, Shangxun Zhou, Yixuan Duan, Daoshen Liu, Kai Xu, Quanmin Jing, Yi Li, Yaling Han
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2025.1606435/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849471658564255744
author Xuefei Mu
Miaohan Qiu
Shangxun Zhou
Shangxun Zhou
Yixuan Duan
Yixuan Duan
Daoshen Liu
Daoshen Liu
Kai Xu
Quanmin Jing
Yi Li
Yaling Han
author_facet Xuefei Mu
Miaohan Qiu
Shangxun Zhou
Shangxun Zhou
Yixuan Duan
Yixuan Duan
Daoshen Liu
Daoshen Liu
Kai Xu
Quanmin Jing
Yi Li
Yaling Han
author_sort Xuefei Mu
collection DOAJ
description ObjectiveThis study aimed to investigate the prognostic value of high-sensitivity cardiac troponin T (hs-cTnT) levels and diabetes mellitus (DM) on ischemic events within 12 months after percutaneous coronary intervention (PCI) in acute coronary syndrome(ACS) patients.MethodsThis retrospective cohort study included 14,173 consecutive ACS patients undergoing PCI at the General Hospital of the Northern Theater Command between March 2016 and March 2022. The primary outcome was the occurrence of ischemic events within 12 months, defined as a composite of cardiac death, non-fatal myocardial infarction (MI), and/or stroke. Secondary outcomes included all-cause mortality at 12 months and the individual components of the primary outcome.ResultsDuring the 12-month follow-up, the overall incidence rates of ischemic events, cardiac death, MI, stroke, and all-cause mortality were 2.19%, 1.12%, 0.58%, 0.59%, and 1.55%, respectively. Elevated hs-cTnT levels were significantly associated with increased risks of ischemic events (adjusted HR: 1.91, 95% CI: 1.19–3.09), cardiac death (adjusted HR: 2.00, 95% CI: 1.08–3.71), and all-cause mortality (adjusted HR: 2.78, 95% CI: 1.62–4.76). In diabetic patients, the risks were particularly pronounced when hs-cTnT levels reached ≥5 × URL. Interaction analyses showed no significant interaction between hs-cTnT levels and diabetes status regarding ischemic events (P = 0.78), but a significant interaction for all-cause mortality (P = 0.01).ConclusionsElevated hs-cTnT levels and the presence of DM are independently associated with an increased risks of ischemic events and all-cause mortality after PCI in ACS patients. The impact of hs-cTnT on mortality is more pronounced in diabetic patients.
format Article
id doaj-art-cee817c02e7e423fbe993fc503f78c64
institution Kabale University
issn 2297-055X
language English
publishDate 2025-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj-art-cee817c02e7e423fbe993fc503f78c642025-08-20T03:24:44ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2025-06-011210.3389/fcvm.2025.16064351606435Prognostic value of elevated postoperative high-sensitivity troponin T in diabetes mellitus patients for ischemic events within 12 months after PCI in ACS patients: a retrospective cohort studyXuefei Mu0Miaohan Qiu1Shangxun Zhou2Shangxun Zhou3Yixuan Duan4Yixuan Duan5Daoshen Liu6Daoshen Liu7Kai Xu8Quanmin Jing9Yi Li10Yaling Han11State Key Laboratory of Frigid Zone Cardiovascular Disease, Cardiovascular Research Institute and Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, ChinaState Key Laboratory of Frigid Zone Cardiovascular Disease, Cardiovascular Research Institute and Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, ChinaState Key Laboratory of Frigid Zone Cardiovascular Disease, Cardiovascular Research Institute and Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, ChinaThe Department of Cardiology, Xijing Hospital, Air Force Medical University, Xi'an, ChinaState Key Laboratory of Frigid Zone Cardiovascular Disease, Cardiovascular Research Institute and Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, ChinaThe Department of Cardiology, Xijing Hospital, Air Force Medical University, Xi'an, ChinaState Key Laboratory of Frigid Zone Cardiovascular Disease, Cardiovascular Research Institute and Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, ChinaThe Department of Cardiology, Xijing Hospital, Air Force Medical University, Xi'an, ChinaState Key Laboratory of Frigid Zone Cardiovascular Disease, Cardiovascular Research Institute and Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, ChinaState Key Laboratory of Frigid Zone Cardiovascular Disease, Cardiovascular Research Institute and Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, ChinaState Key Laboratory of Frigid Zone Cardiovascular Disease, Cardiovascular Research Institute and Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, ChinaState Key Laboratory of Frigid Zone Cardiovascular Disease, Cardiovascular Research Institute and Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, ChinaObjectiveThis study aimed to investigate the prognostic value of high-sensitivity cardiac troponin T (hs-cTnT) levels and diabetes mellitus (DM) on ischemic events within 12 months after percutaneous coronary intervention (PCI) in acute coronary syndrome(ACS) patients.MethodsThis retrospective cohort study included 14,173 consecutive ACS patients undergoing PCI at the General Hospital of the Northern Theater Command between March 2016 and March 2022. The primary outcome was the occurrence of ischemic events within 12 months, defined as a composite of cardiac death, non-fatal myocardial infarction (MI), and/or stroke. Secondary outcomes included all-cause mortality at 12 months and the individual components of the primary outcome.ResultsDuring the 12-month follow-up, the overall incidence rates of ischemic events, cardiac death, MI, stroke, and all-cause mortality were 2.19%, 1.12%, 0.58%, 0.59%, and 1.55%, respectively. Elevated hs-cTnT levels were significantly associated with increased risks of ischemic events (adjusted HR: 1.91, 95% CI: 1.19–3.09), cardiac death (adjusted HR: 2.00, 95% CI: 1.08–3.71), and all-cause mortality (adjusted HR: 2.78, 95% CI: 1.62–4.76). In diabetic patients, the risks were particularly pronounced when hs-cTnT levels reached ≥5 × URL. Interaction analyses showed no significant interaction between hs-cTnT levels and diabetes status regarding ischemic events (P = 0.78), but a significant interaction for all-cause mortality (P = 0.01).ConclusionsElevated hs-cTnT levels and the presence of DM are independently associated with an increased risks of ischemic events and all-cause mortality after PCI in ACS patients. The impact of hs-cTnT on mortality is more pronounced in diabetic patients.https://www.frontiersin.org/articles/10.3389/fcvm.2025.1606435/fullacute coronary syndromepercutaneous coronary interventionhigh-sensitivity cardiac troponin Tdiabetes mellitusischemic events
spellingShingle Xuefei Mu
Miaohan Qiu
Shangxun Zhou
Shangxun Zhou
Yixuan Duan
Yixuan Duan
Daoshen Liu
Daoshen Liu
Kai Xu
Quanmin Jing
Yi Li
Yaling Han
Prognostic value of elevated postoperative high-sensitivity troponin T in diabetes mellitus patients for ischemic events within 12 months after PCI in ACS patients: a retrospective cohort study
Frontiers in Cardiovascular Medicine
acute coronary syndrome
percutaneous coronary intervention
high-sensitivity cardiac troponin T
diabetes mellitus
ischemic events
title Prognostic value of elevated postoperative high-sensitivity troponin T in diabetes mellitus patients for ischemic events within 12 months after PCI in ACS patients: a retrospective cohort study
title_full Prognostic value of elevated postoperative high-sensitivity troponin T in diabetes mellitus patients for ischemic events within 12 months after PCI in ACS patients: a retrospective cohort study
title_fullStr Prognostic value of elevated postoperative high-sensitivity troponin T in diabetes mellitus patients for ischemic events within 12 months after PCI in ACS patients: a retrospective cohort study
title_full_unstemmed Prognostic value of elevated postoperative high-sensitivity troponin T in diabetes mellitus patients for ischemic events within 12 months after PCI in ACS patients: a retrospective cohort study
title_short Prognostic value of elevated postoperative high-sensitivity troponin T in diabetes mellitus patients for ischemic events within 12 months after PCI in ACS patients: a retrospective cohort study
title_sort prognostic value of elevated postoperative high sensitivity troponin t in diabetes mellitus patients for ischemic events within 12 months after pci in acs patients a retrospective cohort study
topic acute coronary syndrome
percutaneous coronary intervention
high-sensitivity cardiac troponin T
diabetes mellitus
ischemic events
url https://www.frontiersin.org/articles/10.3389/fcvm.2025.1606435/full
work_keys_str_mv AT xuefeimu prognosticvalueofelevatedpostoperativehighsensitivitytroponintindiabetesmellituspatientsforischemiceventswithin12monthsafterpciinacspatientsaretrospectivecohortstudy
AT miaohanqiu prognosticvalueofelevatedpostoperativehighsensitivitytroponintindiabetesmellituspatientsforischemiceventswithin12monthsafterpciinacspatientsaretrospectivecohortstudy
AT shangxunzhou prognosticvalueofelevatedpostoperativehighsensitivitytroponintindiabetesmellituspatientsforischemiceventswithin12monthsafterpciinacspatientsaretrospectivecohortstudy
AT shangxunzhou prognosticvalueofelevatedpostoperativehighsensitivitytroponintindiabetesmellituspatientsforischemiceventswithin12monthsafterpciinacspatientsaretrospectivecohortstudy
AT yixuanduan prognosticvalueofelevatedpostoperativehighsensitivitytroponintindiabetesmellituspatientsforischemiceventswithin12monthsafterpciinacspatientsaretrospectivecohortstudy
AT yixuanduan prognosticvalueofelevatedpostoperativehighsensitivitytroponintindiabetesmellituspatientsforischemiceventswithin12monthsafterpciinacspatientsaretrospectivecohortstudy
AT daoshenliu prognosticvalueofelevatedpostoperativehighsensitivitytroponintindiabetesmellituspatientsforischemiceventswithin12monthsafterpciinacspatientsaretrospectivecohortstudy
AT daoshenliu prognosticvalueofelevatedpostoperativehighsensitivitytroponintindiabetesmellituspatientsforischemiceventswithin12monthsafterpciinacspatientsaretrospectivecohortstudy
AT kaixu prognosticvalueofelevatedpostoperativehighsensitivitytroponintindiabetesmellituspatientsforischemiceventswithin12monthsafterpciinacspatientsaretrospectivecohortstudy
AT quanminjing prognosticvalueofelevatedpostoperativehighsensitivitytroponintindiabetesmellituspatientsforischemiceventswithin12monthsafterpciinacspatientsaretrospectivecohortstudy
AT yili prognosticvalueofelevatedpostoperativehighsensitivitytroponintindiabetesmellituspatientsforischemiceventswithin12monthsafterpciinacspatientsaretrospectivecohortstudy
AT yalinghan prognosticvalueofelevatedpostoperativehighsensitivitytroponintindiabetesmellituspatientsforischemiceventswithin12monthsafterpciinacspatientsaretrospectivecohortstudy